CD7 encodes a transmembrane glycoprotein expressed mainly in T cells and natural killer cells [14], which plays an important role in the human immune system and is a potential therapeutic target for hematologic malignancies [15,16]. This evidence concerns the gene CD7 and hematologic disorder.